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ABSTRACT:  Giant strides in knowledge about nanoparticles have lead to the 
development of sophisticated fluorescent quantum dots that have enhanced our 
understanding of the disease process as well as the healing mechanism following 
appropriate therapy. This article focuses on various aspects of fluorescent quantum dots 
which are now knocking at our doors to let them in to assist us in molecular imaging. 
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INTRODUCTION
ᴪ 
 
The first decade of the new millennium has paved 
the way for molecular imaging. Use of fluorescent 
quantum dots is now one of the main cornerstones 
of molecular imaging. Detection of biological 
processes at molecular level needs specialized 
probes. This problem was overcome when 
scientific advances put forth the solution in the 
form of fluorescent quantum dots that produce 
excellent contrast which enables rapid detection of 
changes at molecular levels. 
 
DISCUSSION 
 
As “nano” means one-billionth, “nanotechnology” 
refers to technology that deals with objects having 
nanoscale dimensions between 1.0 and 100.0 nm. 
Because of fundamental principles of quantum 
physics nanoscale materials have different 
properties than the properties of the same materials 
having larger dimensions
1.  Majority of research in 
molecular biology is taking place on a nanoscale as 
all biologic systems are inherently composed of 
nanoscale building blocks
2. After the invention of 
the scanning tunneling microscope in 1981 by 
Binig and Rohrer
3, working on individual atoms on 
a surface became feasible so that nanoscale 
structures could be assembled into larger and more 
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complex structures and nanoscale science grew by 
leaps and bounds. Combination of array technology 
and scanning probe microscope method has further 
widened the horizons. Most of the contrast agents 
being developed for fluorescent optical imaging are 
nanoassemblies that have a fluorescent reporter 
label and a receptor-targeting moiety on a polymer 
backbone
4,5. The term theranostics refers to the 
unique combination of drug and nanocontrast. It 
has a bright future as it promises imaging of a 
protein, drug or even gene delivery system
6. 
The basis of fluorescent imaging by using 
nanoparticles is that they exhibit luminescence. 
Interest in fluorescent quantum dots as an imaging 
tool sprang up after the discovery of green 
fluorescent protein in jelly fish
7. 
Quantum dots score better than organic dyes and 
fluorescent proteins due to their higher 
luminescence, wide excitation with narrow 
emission bands, resistance to photo bleaching and 
high molar extinction coefficient. As the size of 
quantum dots is increased, the wavelength of 
fluorescent emission is also increased
8. 
Moreover many functions can be incorporated in 
one nanosystem as has been demonstrated by the 
development of a nanosystem in which fluorescent 
quantum dots and pharmaceutical drugs are 
assembled into chitosan nanoparticles for 
multifunctional smart drug delivery systems
9.  
The problem of occurrence of hydrophobic organic 
ligands following synthesis has been solved by 
conjugating them with a hydrophilic substance so 
that the solubility of quantum dots is enhanced
10. 
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have been possible by conjugating quantum dots 
with Chitosan [(CdSe-ZnS)-chitosan]. 
Biocompatible and biodegradable Chitosan is an 
obvious choice because of its hydrophilic nature. 
A better alternative is to use silicon quantum dots 
that have a surface hydroxyl group ensuring its 
water solubility. Oxygen-passivation is used to 
stabilize its photoluminescence. Silicon quantum 
dots are not only less cytotoxic alternative to CdSe 
for bio-imaging labels
11, their initially modest yield 
can now be increased exponentially
12. 
Heavy metal-free quantum dot bio-probes based on 
single phase ZnS have been prepared by selectively 
doping them with transition metals and halides to 
provide adjustable luminescence properties. 
Surface conjugation with folic acid enables cancer 
targeting
13. 
The excitation and emission wavelengths of the 
above mentioned quantum dots lie in the visible 
spectrum. This hampers imaging of deeper tissues, 
as these wavelengths are highly absorbed by body 
tissue. Therefore, only superficial tissues can be 
seen  in vivo. Hence while preparing fluorescent 
quantum dots  from non fluorescent nanoparticles, 
the fluorophores that is being used should be such 
that it should both absorb as well as emit light in 
the near-infrared window (650–900 nm), where the 
absorbance of tissue is low
14.This is not so vital 
when using confocal microscopy, where light has 
to penetrate minimal tissue sections but assumes 
more critical stand when using fluorescence 
tomography, where light has to pass through 
substantial tissue thickness. 
Functionalized dots for in vivo tumor vasculature in 
the infrared part of the spectrum have been 
developed by conjugating them with Arginine-
glycine-aspartic acid (RGD) peptides that targets 
actively growing tumor vessels of all cancer 
types
15. This is better than the conventional 
antibody or aptamer-mediated targeting that is 
specific to a particular cancer type. 
Method to increase blood half-lives of 
nanoparticles that are otherwise foreign to the body 
includes PEGylation that avoids fast removal by 
the reticuloendothelial system.  This allows larger 
amount of injected material to reach and bind the 
desired sites. PEGylation lowers cytotoxicity, 
exhibits a 10-fold increase in circulation half-life 
and does not form aggregates in the lungs
16. 
Natural nanoparticles like viruses or lipoproteins 
evade recognition by the body’s defense systems.  
This can be converted into fluorescent tagged 
quantum by modifying their surface to contain 
contrast generating ions and dyes
17,18 or  by 
including inorganic nanoparticles in the core of the 
virus or lipoprotein
19. 
Renal system can excrete nanoparticles up to 5.5 
nm, while particles larger than that are mainly 
taken up by the reticuloendothelial system where 
they end up in the liver and spleen
20. Here they are 
metabolized and excreted or accumulated and can 
potentially become toxic for the body
21. 
Advantages of nanoparticulate fluorescent tagged 
quantum dots over single molecule-based contrast 
agents include
22-29: 
•  Adequate contrast, 
•  Many types of contrast generating materials 
can be utilized at a time, 
•  Circulation time is more, 
•  High payloads are possible, 
•  Quick and efficient assemblage of components 
is possible, 
•  Multiple imaging techniques can be used for 
detection, 
•  Therapeutics can also be delivered and 
visualised, 
•  Particular cell types can also be detected and 
seen, or 
•  Promote and permit development of newer 
imaging systems 
For imaging modalities with low sensitivity, 
nanoparticles bearing multiple contrast groups 
provide signal amplification
30. Some nanoparticles 
enable deep-tissue as well as real-time evaluation 
diverse specimens, such as brain, heart, kidneys 
and lymphatic organs while leaving the tissue 
intact
31. 
 
CONCLUSION 
 
Use of fluorescent quantum dots is of immense 
help in visualizing early stage of disease, its 
progression and response to treatment. Recent 
advances in nanotechnology enable synthesis of a 
nanoparticle contrast agent possessing the required 
attributes for any desired application. Advances in 
molecular imaging, diagnostic imaging and 
nanotechnology must go hand in hand to reap out 
the best fruits from the tree of knowledge for health 
of the entire humanity. 
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